Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States

BACKGROUND: Migraine is a common neurological disease that can have a substantial impact on patients’ lives and on society. Erenumab, a fully human monoclonal antibody that targets the calcitonin gene-related peptide receptor, was specifically developed for migraine prevention. The efficacy of erenu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Stewart J, Fang, Juanzhi, Zhou, Lujia, Shen, Ying, Vo, Pamela, Abdrabboh, Ahmad, Glassberg, Mrudula B, Ferraris, Matias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394219/
https://www.ncbi.nlm.nih.gov/pubmed/33998825
http://dx.doi.org/10.18553/jmcp.2021.21060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394219/
https://www.ncbi.nlm.nih.gov/pubmed/33998825
http://dx.doi.org/10.18553/jmcp.2021.21060

Ejemplares similares